Nasus Pharma Ltd

Important metrics include cash and short-term investments, total assets, current assets, total liabilities, current liabilities, long-term debt, shareholders' equity, retained earnings, inventory, receivables, working capital, current ratio, quick ratio, debt-to-equity ratio, and return on equity. Investors usually review these together rather than relying on one number.

Assets are resources the company owns or controls, such as cash, receivables, inventory, investments, and property. Liabilities are obligations the company owes, such as accounts payable, debt, leases, and taxes. Shareholders' equity is the residual value after liabilities are subtracted from assets.

Current assets and current liabilities are generally expected to be converted, used, paid, or settled within one year or one operating cycle. Non-current assets and non-current liabilities are longer-term items, such as property, long-term investments, deferred tax assets, long-term debt, and lease obligations.

In its most recent quarterly, Nasus Pharma Ltd had 7.82M in cash and cash equivalents.

Nasus Pharma Ltd reported 2.24M in total liabilities as of the latest reported quarter, including 2.16M in current liabilities and 73.00K in non-current liabilities.

As of the latest reported quarter, Nasus Pharma Ltd's total assets were 5.00M, consisting of 4.86M in current assets and 149.00K in non-current assets.

Nasus Pharma Ltd reported 2.77M in total shareholders' equity as of the latest reported quarter.